Pharmafile Logo
Pharmafocus logo
Advanced Search

TNF

Showing 9 posts of 9 posts found.

Abbvie image

AbbVie highlights treatment adherence

June 12, 2014
Sales and Marketing ALIGN, AbbVie, Abbott, Crohn’s disease, TNF, ankylosing spondylitis, psoriasis, psoriatic arthritis, rheumatoid arthritis, treatment, ulcerative colitis

Patients with inflammatory diseases tend to be better at following their treatment regimes with TNF inhibitors rather than other medicines, …

News
Abbott image

Abbott buys into Galapagos’ RA candidate

February 29, 2012
Research and Development, Sales and Marketing Abbott, Galapagos, Humira, JAK, RA, TNF

Abbott has struck a deal with Galapagos to develop and commercialise a promising oral JAK1 inhibitor to treat multiple autoimmune …

News

Price concession helps change NICE’s mind on Simponi

May 13, 2011
Sales and Marketing NICE, Simponi, TNF, merck sharp and dohme

NICE has provisionally recommended Merck Sharp & Dohme’s Simponi for rheumatoid arthritis alongside other drugs in the TNF inhibitor class. …

News
Abbott's Humira (adalimumab)

Abbott wins $1.7bn Humira case

February 24, 2011
Sales and Marketing Abbott, Abbott Laboratories, Centocor, Johnson and Johnson, Remicade, Simponi, TNF, golimumab, infliximab, rheumatoid arthritis

Abbott has been saved from paying Johnson & Johnson $1.7 billion after a US appeals court quashed a patent dispute …

News

NICE re-thinks arthritis guidance

June 25, 2010
Sales and Marketing Enbrel, Humira, MabThera, NICE, Orencia, Remicade, TNF, rheumatoid arthritis

NICE has approved five rheumatoid arthritis treatments in certain circumstances after treatment with a tumour necrosis factor inhibitor has failed. …

News

Ulcerative colitis market set to double by 2018

February 12, 2010
Sales and Marketing Humira, Simponi, TNF, ulcerative colitis

The market for ulcerative colitis drugs is set to double over the ten years to 2018 when it will hit …

News

Simponi approved in Europe

October 8, 2009
Sales and Marketing RA, Simponi, TNF

 Rheumatic disease drug Simponi has received marketing approval for Europe, where it will be marketed by Schering-Plough.The drug is indicated …

News

TNF blockers must carry children’s cancer warning

August 7, 2009
Research and Development, Sales and Marketing FDA, RA, TNF

The FDA has ruled that TNF blocker drugs should carry new warnings of the increased risk of certain cancers for …

News

Remicade loses out in ankylosing spondylitis

November 15, 2007
Sales and Marketing TNF

NICE has rejected Schering-Plough's Remicade as a treatment for the debilitating form of spinal inflammation known as ankylosing spondylitis.The Institute …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026